Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.678 EUR | -0.59% | -8.42% | -22.08% |
Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.08% | 548M | |
-1.82% | 41.35B | |
+41.53% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva COVID-19 Vaccine Reportedly Not Recommended by French Regulator